🇪🇺 Twinrix ™ Paediatric in European Union

EMA authorised Twinrix ™ Paediatric on 10 February 1997

Marketing authorisation

EMA — authorised 10 February 1997

  • Application: EMEA/H/C/000129
  • Marketing authorisation holder: GlaxoSmithKline Biologicals S.A.
  • Local brand name: Twinrix Paediatric
  • Indication: Twinrix Paediatric is indicated for use in non-immune infants, children and adolescents from one year up to and including 15 years who are at risk of both hepatitis-A and hepatitis-B infection.
  • Status: approved

Read official source →

Other Infectious Diseases approved in European Union

Frequently asked questions

Is Twinrix ™ Paediatric approved in European Union?

Yes. EMA authorised it on 10 February 1997.

Who is the marketing authorisation holder for Twinrix ™ Paediatric in European Union?

GlaxoSmithKline Biologicals S.A. holds the EU marketing authorisation.